Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Gains from Investment Securities (2016 - 2025)

CV Sciences' Gains from Investment Securities history spans 13 years, with the latest figure at $908000.0 for Q3 2025.

  • For Q3 2025, Gains from Investment Securities changed N/A year-over-year to $908000.0; the TTM value through Sep 2025 reached $908000.0, changed N/A, while the annual FY2024 figure was $26.8 million, 9.77% up from the prior year.
  • Gains from Investment Securities for Q3 2025 was $908000.0 at CV Sciences, up from $130000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $26.8 million in Q4 2024 and bottomed at -$341000.0 in Q3 2022.
  • The 5-year median for Gains from Investment Securities is $30000.0 (2025), against an average of $4.9 million.
  • The largest annual shift saw Gains from Investment Securities plummeted 537.5% in 2022 before it surged 1168600.0% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at -$32000.0 in 2021, then tumbled by 537.5% to -$204000.0 in 2022, then soared by 12077.94% to $24.4 million in 2023, then grew by 9.77% to $26.8 million in 2024, then tumbled by 96.61% to $908000.0 in 2025.
  • Per Business Quant, the three most recent readings for CVSI's Gains from Investment Securities are $908000.0 (Q3 2025), $130000.0 (Q2 2025), and $30000.0 (Q1 2025).